Skyscape Web Viewer : Radiation Oncology Question Review : Main Index

View All
Langerhans cell histiocytosis (LCH) age group Answer 10.41 long-term sequelae and sex predominance common complication radiation therapy
Larynx/hypopharynx anticipated local control indications phase III VA trial RTOG T1N0 glottic tumors altered fractionation incidence organ preservation strategies preservation salvage laryngectomy
LCIS
Liver tumors in children benign vs malignant hepatoblastomas histopathology staging system adjuvant radiation, doses for hemangioblastoma hepatocellular carcinoma neoadjuvant radiation, doses for typical presentation
lobular carcinoma in situ (LCIS) Answer 3.50 Answer 3.52 Answer 3.51 Question 3.50 Question 3.52 Question 3.51
LACE meta-analysis
LCH
Locally advanced breast cancer constraints dermal lymphatic invasion eligibility criteria lymphedema postmastectomy radiation therapy (PMRT) trial WBI and RNI characteristics danish PMRT trials diagnosis locoregional recurrence neoadjuvant chemotherapy treatment
Locally advanced squamous cell cancer Question 1.3 Question 1.1
Lung Adjuvant Cisplatin Evaluation (LACE) meta-analysis
lymphocyte-predominant Hodgkin lymphoma (LPHL) Answer 8.47 Question 8.47 Answer 8.46 Question 8.46
LPHL